Mohd. Zaheen Hassan

Dr. Mohd. Zaheen Hassan

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MHMohd. Zaheen Hassan
Mohd. Zaheen Hassan
HOHasnah Osman
Hasnah Osman
MAMohamed Ashraf Ali
Mohamed Ashraf Ali
MOHAMED JAWED AHSANMOHAMED JAWED AHSAN
MOHAMED JAWED AHSAN

24 July 2020 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
YAYahya I Asiri
Yahya I Asiri
AAAbdulrhman Alsayari
Abdulrhman Alsayari
AMAbdullatif B. Muhsinah
Abdullatif B. Muhsinah
YMYahia N. Mabkhot
Yahia N. Mabkhot
MHMohd. Zaheen Hassan
Mohd. Zaheen Hassan
Objectives: The recent viral pandemic poses a unique challenge for healthcare providers. Despite the remarkable progress, the number of novel antiviral agents in the pipeline is woefully inadequate against the evolving virulence and drug resistance of current viruses. This highlights the urgent need for new and improved vaccines, diagnostics and therapeutic agents to obviate the viral pandemic. Key findings: Benzothiazole plays a pivotal role in the design and development of antiviral drugs. This is evident from the fact that it comprises many clinically useful agents. The current review is aimed to provide an insight into the recent development of benzothiazole-based antiviral agents, with a special focus on their structure-activity relationships and lead optimisation. One hundred and five articles were initially identified, and from these studies, 64 potential novel lead molecules and main findings were highlighted in this review. Summary: We hope this review will provide a logical perspective on the importance of improving the future designs of novel broad-spectrum benzothiazole-based antiviral agents to be used against emerging viral diseases.

1 March 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AAAbdulrahman Alsayari
Abdulrahman Alsayari
AMAbdullatif Bin Muhsinah
Abdullatif Bin Muhsinah
MHMohd. Zaheen Hassan
Mohd. Zaheen Hassan
MOHAMED JAWED AHSANMOHAMED JAWED AHSAN
MOHAMED JAWED AHSAN
JAJaber Abdullah Alshehri
Jaber Abdullah Alshehri
NBNaseem Begum
Naseem Begum

5 July 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FAFahad Saad Alhodieb
Fahad Saad Alhodieb
MBMd. Abul Barkat
Md. Abul Barkat
MBMd. Abul Barkat
Md. Abul Barkat
Hazrina HadiHazrina Hadi
Hazrina Hadi
MKMohammad Idreesh Khan
Mohammad Idreesh Khan
AAAbdulkareem Ali Alanezi
Abdulkareem Ali Alanezi

5 July 2021 in Journal of Oncology
Verified
Journal Article
Open access
AAAbdulrhman Alsayari
Abdulrhman Alsayari
YAYahya I. Asiri
Yahya I. Asiri
AMAbdullatif Bin Muhsinah
Abdullatif Bin Muhsinah
MHMohd. Zaheen Hassan
Mohd. Zaheen Hassan
Anticolon Cancer Properties of Pyrazole Derivatives Acting through Xanthine Oxidase Inhibition: Background. Pyrazoles are an interesting class of compounds showing potent anticancer activities. Our previous studies have demonstrated the potent anticancer activity of pyrazole analogues. Therefore, we focused on developing anticancer agents through structure optimization of the pyrazolyl lead molecule. Methods. The pyrazole derivatives were prepared by the appropriate synthetic protocols. The antiproliferative activities were evaluated using a sulforhodamine B assay against three cancer cell lines. In vitro and in silico molecular docking studies employing xanthine oxidase were used to explore the mechanism by which pyrazole derivatives exert anticancer effects. Results. One of the pyrazole derivatives demonstrated the greatest promise as an anticancer agent against the human colon cancer cell line (IC50 4.2μM), with a potent xanthine oxidase inhibitory activity (IC50 0.83μM). Conclusion. In summary, our findings suggest that these pyrazolyl analogues containing a pyridine nucleus could serve as a promising lead molecule in the development of novel anticancer agents.

1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SMShobhit Mishra
Shobhit Mishra
FAFahad Saad Alhodieb
Fahad Saad Alhodieb
MBMd. Abul Barkat
Md. Abul Barkat
MHMohd. Zaheen Hassan
Mohd. Zaheen Hassan
MBMd. Abul Barkat
Md. Abul Barkat
OAOzair Alam
Ozair Alam